How to adjust your biological clock (and live longer)
“Time is money,” Benjamin Franklin taught in the 18th century. However, the rational use of time requires an understanding of human limits that seems to have been lost in this…
Continue reading“Time is money,” Benjamin Franklin taught in the 18th century. However, the rational use of time requires an understanding of human limits that seems to have been lost in this…
Continue readingWashington Olivetto was a gift in my life. I was working at McCann when W/Brasil joined the agency and we became WMcCann. It was a process that had the potential…
Continue readingNelson Rodrigues preached that all unanimity is stupid – but the playwright’s maxim deserves to be questioned in the face of the show Prima Facie. Since April, when it premiered…
Continue readingNetflix continues to grow and generate cash while its competitors struggle not to lose money. With an extraordinary culture and a huge opportunity to further expand its market through advertisements,…
Continue readingVeteran of vehicles like Veja, Estadão, Correio Braziliense, and O Globo, journalist Rodrigo Rangel is venturing into entrepreneurship for the first time, launching a new website to cover Brasília with…
Continue readingChicão Bulhões — the current Secretary of Urban and Economic Development of the City of Rio de Janeiro — will take on an executive position at PRIO, returning to the…
Continue readingXP has updated its coverage of paper and pulp, upgrading Klabin and Irani from ‘neutral’ to ‘buy’ – with potential upsides of 33% and 26%, respectively – and naming Suzano…
Continue readingRandoncorp is buying the British brake distributor European Braking Systems (EBS) for 56 million pounds – about R$ 410 million. The deal, closed through Master Freios – a joint venture…
Continue readingAssaí has cut in half its projection for opening new stores next year, in an effort by CEO Belmiro Gomes to decrease its capex and accelerate deleveraging. The wholesale network…
Continue readingSantander has reestablished its coverage of Ambev, changing the recommendation from ‘buy’ to ‘neutral’ and reducing the price target from R$ 18.50 to R$ 15. The new price target implies…
Continue reading